INTRODUCTION
Monocytes/macrophages are prominent cells in chronic inflammation, such as arthritis, atherosclerosis, and periodontal disease, in which degradation of the connective tissue is a major contributing factor to the pathology associated with these diseases. Destruction of the connective tissue in these lesions is believed to be a result of the action of matrix metalloproteinases (MMPs), which are comprised of a family of enzymes that include interstitial collagenases, gelatinases, stromelysin, matrilysin, metalloelastase, and membrane-type MMPs [1] [2] [3] . Collectively, MMPs can degrade all the components of the extracellular matrix (ECM). Stimulation of monocytes with lipopolysaccharide (LPS), a surface component of gram-negative bacteria, or the combination of granulocyte macrophagecolony stimulating factor (GM-CSF) ϩ tumor necrosis factor ␣ (TNF-␣) induces a number of MMPs, including MMP-9 (gelatinase B), which degrades collagen denatured (gelatin) by MMP-1, -8, and -13 cleavage of fibrillar collagens, such as types I, II, and III. Additionally, MMP-9 degrades laminin and type IV collagen, components of the basement membrane. Thus, these enzymes are involved in the connective tissue loss associated with chronic inflammatory diseases as well as the migration of cells out of the bloodstream and through the ECM.
Production of MMPs by human monocytes/macrophages following stimulation with agents such as concanavalin A, LPS, or ECM components occurs, in part, through a prostaglandin E 2 (PGE 2 )-cyclic adenosine monophosphate-dependent pathway [4 -8] . In contrast, stimulation of monocytes with GM-CSF and/or TNF-␣ induces MMP-9 through a PG-independent pathway [9] . However, cytokine-induced MMP-9 can be enhanced by the addition of exogenous PGE 2 [10] . These findings indicate that multiple pathways are involved in the induction of MMPs.
We have previously shown that LPS induces production of MMP-9 by monocytes through the nuclear factor (NF)-B pathway [10] . However, the upstream components involved in the activation of NF-B that lead to MMP-9 production by monocytes still remain to be elucidated. Several studies using cell lines have demonstrated that NF-B can be regulated by Akt/protein kinase B (PKB) through inhibitor of 〉 (⌱〉) kinase (IKK)/⌱〉 in a cell-and stimulus-specific manner [11] [12] [13] [14] . Recent evidence has demonstrated that the cell spec-ificity of NF-B activation by Akt is dependent on a high proportion of IKK␣ to IKK␤ in cells [15] . Therefore, our objective was to examine the potential role of Akt in the signaling pathway leading to the production of MMP-9 in monocytes stimulated with LPS. Here, we report that LPS induces the production of MMP-9 by human primary monocytes through a pathway involving Akt, IKK␣, and NF-B.
MATERIALS AND METHODS

Reagents
The following antibodies and reagents were used: antiphospho-Akt (Ser473; Calbiochem, San Diego, CA); anti-MMP-9 (Chemicon, Temecula, CA), antiAkt1/2, mouse immunoglobulin G (IgG) agarose beads, anti-IKK␣ agarose beads, anti-IKK␣, anti-IKK␤, and protein A/G agarose beads (Santa Cruz Biotechnology, CA); LPS (Difco, Detroit, MI); wortmannin, LY294002, lactacystin, and MG-132 (Z-Leu-Leu-Leu-Chinese hamster ovary, Biomol, Plymouth Meeting, PA); SH-5 (Alexis Biochemicals, San Diego, CA); phosphoglycogen synthase kinase (GSK)-3␣/␤ (Ser21/9) antibody, GSK-3 fusion protein, kinase buffer, and adenosine 5Ј-triphosphate (ATP; Cell Signaling Technology, Beverly, MA); elution buffer (Pierce Biotechnology, Rockford, IL); and nuclear extract kit, TransAM TM NF-B transcription factor assay kit (Active Motif, Carlsbad, CA).
Purification of human monocytes and culture conditions
Human peripheral blood monocytes were obtained by leukapheresis of normal volunteers at the Department of Transfusion Medicine at the National Institutes of Health (Bethesda, MD). The monocytes were purified by counter-flow centrifugal elutriation as described previously [10] . Monocytes were enriched to Ͼ90%, as determined by morphology, nonspecific esterase staining, and flow cytometry. Purified monocytes were cultured in Dulbecco's modified Eagle's medium (DMEM; BioWhittaker, Walkersville, MD), supplemented with 2 mM L-glutamine (Mediatech, Herndon, VA) and 10 g/ml gentamicin sulfate (BioWhittaker) at 37°C in a humidified atmosphere containing 5% CO 2 .
LPS, wortmannin, LY294002, lactacystin, and SH-5 were added to some of the cultures. Dimethyl sulfoxide (Me 2 SO) was used to dissolve some of the reagents, and the highest final concentration added to the culture was 0.1%. Unless otherwise stated, monocytes were adhered for 30 min before the addition of reagents. Each experiment was repeated a minimum of three times with different donors.
Detection of MMP-9 by Western blot analysis
For determination of the protein levels of MMP-9 produced by monocytes, proteins in the supernatants of 48 h-conditioned medium were precipitated with cold ethanol (final concentration of 60%) at -70°C as described previously [10] . The proteins from equal portions of the conditioned medium were separated on a Novex 8 -16% Tris-glycine polyacrylamide gel (Invitrogen, Carlsbad, CA) and then transferred onto nitrocellulose membranes, which were blocked with 5% nonfat dry milk in a buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCI, and 0.1% Tween 20. The membranes were then incubated overnight with primary antibodies. Western blots were analyzed by the addition of Alexa Fluor 680 secondary antibody (Molecular Probes, Eugene, OR), and the infrared fluorescence was detected with the Odyssey infrared imaging system (LI-COR, Lincoln, NE). The fluorescence intensity of each blot was measured with the densitometric program in the Odyssey infrared imaging system.
Immunopreciptation and Western blot assay
Monocytes were harvested at specific times after treatment with reagents and lysed in lysis buffer [20 mM, pH 7.5, Tris, 150 mM NaC1, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerolphosphate, 1 mM Na 3 VO 4 , and a cocktail of proteinase inhibitors (Roche Molecular Biochemicals, Indianapolis, IN)]. After equalizing the protein to 1.5 mg/300 l in a 1.5-ml Eppendorf tube, the appropriate antibody bound to agarose beads was added, and the samples were rotated overnight at 4°C. After the beads were washed three times with lysis buffer, the samples were subjected to Western blot analysis as described above. The membranes were then stripped with elution buffer and reprobed with antibodies against the nonphosphorylated protein as a measure of equal loading. Controls for the immunoprecipitation used the same procedure, except agarose beads contained only mouse IgG. 
Akt kinase assay
Monocytes were harvested at specific times after treatment with reagents and lysed in lysis buffer. After equalizing the protein to 1.0 mg/200 l in a 1.5-ml Eppendorf tube, 10 l Aktl/2 antibody was added, and the samples were rotated overnight at 4°C. Then 20 l protein A/G agarose bead slurry was added, and the samples were rotated at room temperature for 2 h. The beads were washed twice with lysis buffer and kinase buffer, and the samples were suspended in 50 l kinase buffer supplemented with 1 l 10 mM ATP and 1 g GSK-3 fusion protein and incubated at 30°C for 30 min. The phosphorylation of GSK-3 fusion protein was analyzed by Western blot with phosphor-GSK-3␣/␤ (Ser2119) antibodies.
NF-B p65 activiation assay
Monocytes were harvested at specific times after treatment with reagents, and the nuclear extracts and the activation assay of p65 were performed according to the instructions of the manufacturer of the TransAM TM /NF-B kit. Briefly, 2 g/well nuclear extract protein was added to a microtiter plate coated with a specific oligonucleotide of p65. The coated plate was then incubated for 1 h at room temperature with mild agitation, after which a primary antibody recognizing the p65 was added, and the plate was incubated for an additional 1 h at room temperature. Anti-IgG horseradish peroxidase-conjugated secondary antibody was then added, and the plate was incubated for 1 h at room temperature. At the end of the hour, the developing and stop solution were added, and an optical density of 450 nm (OD 450 ) was read on a Wallac Victor 1420 multilabel counter (Perkin Elmer Life Sciences, Shelton, CT). Three duplicates were done for each sample.
RESULTS
Phosphatidylinositol-3 kinase (PI-3K)/Akt pathway is involved in monocyte MMP-9 expression
The effect of various doses of LPS on MMP-9 production by monocytes was assessed to correlate the MMP-9 levels with the induction of signaling components leading the synthesis of the enzyme (Fig. 1A) . Barely detectable levels of MMP-9 were induced by 6 ng/ml LPS, whereas significant increases in MMP-9 occurred from 12.5 to 100 ng/ml LPS. To determine the involvement of PI-3K through its regulation of Akt in the MMP-9 production by human primary monocytes, we initially examined the effect of PI-3K activity on the induction of MMP-9 by LPS. The addition of LY294002 or wortmannin, inhibitors of PI-3K, suppressed the MMP-9 production induced by LPS (Fig. 1B) . Addition of LY294002 at 2.5 M resulted in a 50% inhibition of MMP-9, whereas 5 M caused 90% inhibition of MMP-9, which by wortmannin, was detected at 25 nM with a 60 -70% inhibition at 50 -100 nM. We next examined whether Akt, a downstream signaling component of PI-3K, was regulating MMP-9. SH-5, an inhibitor of the phosphorylation and subsequent activity of Akt, blocked the induction of MMP-9 by LPS in a dose-dependent manner (Fig. 1C) . Inhibition of MMP-9 by SH-5 was detected at 2.5 M with almost complete inhibition at 5 M. These results demonstrate that PI-3K and Akt are involved in the regulation of MMP-9 production.
LPS activates Akt in monocytes
The ability of the Akt inhibitor SH-5 to block MMP-9 production indicated that Akt was activated when monocytes were stimulated. Therefore, following stimulation of the monocytes by LPS, the serine 473 phosphorylation form of Akt1 was examined by immunoblot. As shown in Figure 2A , LPS caused a dose-dependent activation of Akt, as demonstrated by an increase in the phosphorylation of Akt1, which corresponded to the LPS doses that induced MMP-9. LY294002 or wortmannin inhibited activation of Akt (Fig. 2B ) at doses that also inhibited MMP-9. To assess the pathway components involved in the activation of Akt, an inhibitor of PI-3K (wortmannin), Akt (SH-5), and NF-B (MG-132) was added to monocyte cultures. As shown in Figure 2C , Akt1/2 activity induced by LPS was inhibited by wortmannin and SH-5, whereas the NF-B inhibitor MG-132 had no effect. These findings demonstrate that PI-3K regulates phosphorylation of Akt, whereas NF-B is downstream and does not influence Akt in monocytes. 
NF-B is involved in the regulation of monocyte MMP-9 expression
Akt has been shown to exert many of its downstream effects through NF-B. To determine the role of NF-B in the regulation of MMP-9, proteasome inhibitors (MG-132 and lactacystin), which suppress NF-B activation by blocking IB degradation, were added to monocytes. Both proteasome inhibitors were effective in the suppression of MMP-9 production, and 10 M MG-132 or 2.5 M lactacystin caused complete inhibition of MMP-9 (Fig. 3, A and B) .
Akt regulates NF-B activation in LPS-stimulated monocytes
Previous studies indicate that Akt regulates NF-B activation through its interaction with IKK␣ but not IKK␤, which is involved in the phosphorylation of IB bound to NF-B [13] [14] [15] . Once IB is phosphorylated, it is ubiquitinated and degraded by the proteasome complex, allowing NF-B to translocate to the nucleus. To determine if Akt regulated NF-B activation in the monocyte in this manner, we first examined the IKK␣/KK␤ proportion in human monocytes because of the variation in the IKK␣/KK␤ ratio found in various cell lines [15] . As shown in Figure 4A , IKK␣ is predominant, whereas IKK␤ is expressed at low levels in monocytes. This is in contract to the monocyte cell line THP-1, in which there is a substantial level of IKK␤. Second, we analyzed the interaction between IKK␣ and Akt. As shown in Figure 4B , using primary human monocytes, there is an association of Akt1/2 with IKK␣ that is independent of monocyte activation. Use of mouse IgG as a control in the immunoprecipitation procedure did not pull down Akt1/2 or IKK␣ (Fig. 4C) .
We next evaluated whether there was a correlation between the phosphorylation of Akt and IKK␣ in the Akt/IKK␣ complex. As shown in Figure 5A , the phosphorylation of Akt (Ser473) and IKK␣ (Thr23) in the complex of IKK␣/Akt corresponded to the dose of LPS (Fig. 5A) . Additionally, the phosphorylation of Akt and IKK␣ in the complex was inhibited by wortmannin and SH-5 but not by MG-132 (Fig. 5B) . Finally, we analyzed the degradation of IB by Western blot (Fig. 6, A and C) and the activation of p65 by enzyme-linked immunosor- Fig. 6 . Akt regulates the activity of NF-B in primary human monocytes through the degradation of IB. Monocytes were treated with LPS for 2 h, and then (A) cell lysates were analyzed by Western blot with anti-IB and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a measure of equal sample-loading amount; (B) cell nuclear extracts were prepared, and the activation of p65 was analyzed by ELISA; (C) monocytes were treated with MG-132, SH-5, or wortmannin for 30 min prior to the addition of LPS for 2 h, and then the cell lysates were prepared and immunoprecipitated with anti-p50 and analyzed by Western blot with anti-IB or anti-GAPDH; and (D) monocytes were treated with MG-132, SH-5, or wortmannin for 30 min prior to the addition of LPS for 2 h, and the nuclear extracts were analyzed for the activation of p65 by ELISA. bent assay (ELISA; Fig. 6 , B and D) after the treatment of LPS in the absence or presence of specific inhibitors. Activation of monocytes with LPS resulted in degradation of IB and activation of p65, which were blocked by inhibitors of PI-3K (wortmannin), Akt (SH-5), and proteasome (MG-132; Fig. 6 ). These findings demonstrate that Akt is a central component in the pathway leading to the downstream activation of NF-B in monocytes and the subsequent production of MMP-9. The LPS-induced PI-3K/Akt/IKK␣/NF-B pathway leading to monocyte MMP-9 production and the specific inhibitors of this pathway are summarized in Figure 7 .
DISCUSSION
Activation of Akt involves its plasma membrane translocation [16] as a result of its pleckstrin homology (PH) domain, which binds to PIP3. PI-3K is activated by tyrosine kinase and G-protein-coupled receptors in the plasma membrane. Following its recruitment to these receptors in the plasma membrane, PI-3K is activated and phosphorylates phosphatidylinositol-4,5-bisphosphate on the 3-OH group, generating the second messenger PIP3, whose levels are tightly regulated by the action of phosphatases such as phosphatase and tensin homolog deleted on chromosome 10, which removes phosphate from the 3-OH position, and Src homology domain-containing inositol phosphatase, which dephosphorylates PIP3 at the 5-OH position. PIP3 does not activate Akt directly but instead, appears to recruit Akt to the plasma membrane and to alter its conformation to allow subsequent phosphorylation by the phosphoinositide-dependent kinase-I [17, 18] . When the capability for PI-3K to produce PIP3 was blocked in monocytes by LY294002 or wortmannin, MMP-9 production was inhibited (Fig. 1B) . This indicates that the PI-3K pathway has a central role in regulation of monocyte MMP-9 production following stimulation by LPS. Furthermore, when SH-5 MMP-9 blocked Akt phosphorylation specifically, production was inhibited (Fig. 1C) . These data show that PIP3 mediates MMP-9 production in monocytes, primarily through Akt and not other downstream components of PI-3K containing a PH domain, such as Vav and the members of the Tec tyrosine kinase family [16] . LPS activates Akt in many cell lines [11-13, 19, 20] . Our data demonstrate that LPS also activates Akt in human primary monocytes leading to the production of MMP-9.
Three members of the Akt family have been isolated, and these are now referred to as Akt1/PKB␣, Akt2/PKB␤, and Akt3/PKB␥. They are products of distinct genes but are highly related, exhibiting greater than 80% homology at the amino acid level [21] . The three genes are expressed differentially: Akt1/PKB␣ and Akt2/PKB␤ are widely displayed, and Akt3/ PKB␥ has a restricted tissue distribution. Of interest in our studies is that Akt1 and Akt2 are expressed and associated with IKK␣ in control or activated monocytes (Fig. 4B) . This indicates that Akt associates with IKK␣ constitutively, at least in the monocyte. This is consistent with the finding in other cell types stimulated with platelet-derived growth factor [14] , TNF [13] , and LPS [22] . IKK is a complex composed of three subunits: IKK␣ (IKK1), IKK␤ (IKK2), and IKK␥ {NF-B essential modulator (NEMO), IK␤ kinase associated protein-1 (IKKAP-1) [23] }. IKK␣ and IKK␤ are the catalytic subunits of the complex, sharing 52% overall sequence identity and 65% identity in their catalytic domains. The third subunit, IKK␥/ NEMO, is the regulatory subunit and is not related to the catalytic subunits [24] . Expression and the ratio of IKK␣ to IKK␤, which homo-and heterodimerize, vary among cell types. NF-B, in the cells with a high proportion of IKK␣ to IKK␤, is sensitive to Akt activity [15] . Our data show that IKK␣ is predominant in human primary monocyte, whereas IKK␤ is barely detectable. This is in contrast to a monocyte cell line THP-1, which has a significant amount of IKK␤ (Fig. 4A) . These data indicate that there may be considerable variation in the ratio of IKK␣ to IKK␤ between primary monocytes and monocyte cell lines, such as THP-1. Gel-filtration analysis indicates that IKK is a large complex, 700 -900 kDa in size, suggesting the presence of additional components. Recently, Cdc 37 and Hsp 90 were suggested to serve as components of the IKK complex [25] . Based on our data (Fig. 4B) , we hypothesize that Aktl and Akt2 may also serve as additional components of the IKK␣ homodimmer complex in the primary monocyte. Cell stimulation with a variety of agonists triggers signal transduction pathways that ultimately result in activation of a specific IKK [23] . Our data show that Akt binds to IKK␣ constitutively, and their phosphorylation occurs following with LPS stimulation (Fig. 5A) ; moreover, the phosphorylation of Akt is regulated by PI-3K, and Akt subsequently phosphorylates IKK␣, as demonstrated with inhibitors (Fig. 5B) .
Phosphorylation of IBs by phosphorylated IKK tags them for polyubiquitination by a specific ubiquitin ligase belonging to the Skp-l/Cul/F box family [26] . The actual recognition of N-terminally phosphorylated IBs is carried out by a WD repeat-and F box-containing protein, ␤-TrCP [26] . Upon ubiquitination, the IB proteins are degraded rapidly by the pro- teasome complex, thereby freeing NF-B, which then enters the nucleus, binds to DNA, and activates transcription. It has been shown that Akt regulates NF-B activation directly through activation of IKK or phosphorylation of RelA [27, 28] . Our findings demonstrated that the PI-3K/Akt pathway also regulates ⌱〉 degradation and activation of NF-B in human primary monocytes stimulated by LPS (Fig. 6) .
In summary, the findings presented here demonstrate that activation of monocytes by LPS induces MMP-9 through a PI-3K/Akt/IKK␣/NF-B pathway, as outlined in Figure 7 . This pathway can be interrupted by inhibition of PI-3K, Akt, or the proteasome complex. These data further our understanding of the pathways included in the regulation of MMP-9 and suggest a possible avenue for intervention in connective tissue destruction.
